QIR Suite vs VX1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by CASIS Cardiac Simulation & Imaging Software
VS
by Volta Medical

AI Verdict

Tool A, QIR Suite, specializes in AI-based analysis of cardiovascular MR and CT images to support diagnosis and prognosis by quantifying various cardiac parameters. Conversely, Tool B, VX1, offers real-time AI guidance to cardiac electrophysiologists during atrial fibrillation and atrial tachycardia ablation procedures by identifying dispersed electrograms. While both are cardiology AI tools, they address distinct clinical needs: imaging diagnostics versus interventional electrophysiology.

Choose QIR Suite if…

Choose QIR Suite if your primary need is comprehensive, AI-powered quantitative analysis of cardiovascular MR and CT images for diagnostic and prognostic purposes. This tool excels at automatically segmenting heart regions, detecting pathological areas, and quantifying over 100 clinical parameters to support detailed evaluation of heart conditions.

View QIR Suite →

Choose VX1 if…

Choose VX1 if you are an electrophysiologist seeking real-time, AI-guided assistance during atrial fibrillation and atrial tachycardia ablation procedures. This software is specifically designed to identify dispersed electrograms, integrate with your existing EP lab systems, and help standardize outcomes by reducing inter-operator variability during complex ablations.

View VX1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature QIR Suite VX1
Pricing Contact for pricing Contact for pricing
Deployment Locally on dedicated hardware Software integrated with existing electrophysiology (EP) lab mapping and recording systems.
FDA Status Cleared AI-estimated Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

VX1

VX1 integrates in real-time with existing electrophysiology lab systems and is compatible with most catheters and mapping technologies, facilitating a fast learning curve for operators. QIR Suite, while offering comprehensive post-processing and aiming to reduce manual correction with 'anatomical guarantee' algorithms, operates locally on dedicated hardware and focuses on imaging analysis rather than real-time procedural guidance.

Clinical Value

VX1

VX1 has demonstrated significant clinical outcomes in proof-of-concept studies, showing high freedom from atrial fibrillation and acute AF termination rates, and aims to standardize ablation outcomes. While its FDA clearance notes that clinical significance for directing treatment is not yet established by clinical investigations, its real-time assistance during procedures directly impacts intervention. QIR Suite, also FDA cleared, provides comprehensive quantitative analysis for diagnosis and prognosis, which is valuable for patient management but does not have published clinical trial outcomes for direct patient impact.

Pricing & Value

Tie

Both tools require direct contact for pricing, indicating a lack of public transparency. QIR Suite offers flexible pricing models including a one-time license fee and subscription options, which could provide varied value propositions. Without specific pricing details for either product, a definitive comparison of their value is not possible.

Enterprise Readiness

VX1

VX1 is designed for broad compatibility with existing EP lab mapping and recording systems, suggesting seamless integration into diverse hospital environments. Volta Medical also emphasizes 'highest standards of data protection,' indicating a focus on enterprise-level compliance. QIR Suite integrates with PACS and HL7, but its local deployment on dedicated hardware might introduce more IT overhead compared to VX1's integration approach.

Innovation

VX1

VX1 represents a significant innovation as the 'first FDA clearance for an AI based tool in interventional cardiac electrophysiology,' providing real-time, AI-guided assistance during live ablation procedures. This direct, real-time interventional application of AI to standardize complex surgical outcomes is a higher degree of innovation. QIR Suite's innovation lies in its comprehensive, multi-modal quantitative imaging analysis and unique 'anatomical guarantee' algorithms, advancing diagnostic capabilities.

Support & Docs

VX1

Volta Medical explicitly mentions a 'VX1TM SYSTEM USER MANUAL' in its documentation, indicating formal support resources are available. Both companies provide contact information for support. However, QIR Suite's available information does not explicitly detail user manuals or dedicated support documentation beyond general contact details and regulatory publications.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature QIR Suite VX1
Name QIR Suite VX1
Company CASIS Cardiac Simulation & Imaging Software Volta Medical
Description AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis. Volta Medical's VX1 is an FDA-cleared AI software that assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
Key Features AI-based analysis of MR and CT examinations; Detection of heart regions and pathological areas; Quantification of over 100 clinical parameters; Automatic segmentation; Blood flow/velocities quantification; Pathological volumes detection and quantification; Semi-quantification of myocardial perfusion; Strain quantification AI-guided real-time identification of dispersed electrograms (EGMs); Assists cardiologists during AFib and atrial tachycardia ablation procedures; Analyzes 3D anatomical and electrical maps of human atria; Compatible with most EP recording, 3D navigation systems, and mapping catheters; Designed to reduce inter-operator variability and standardize outcomes; Provides cycle length estimation from electrograms; Booster mode for increased sensitivity during AT or slow AF

Videos

Demos, reviews, and walkthroughs featuring QIR Suite and VX1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

QIR Suite is an AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis, primarily for cardiologists and radiologists. VX1 is an AI software designed to assist cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.
QIR Suite analyzes MR and CT images to detect heart regions, pathological areas, and quantify clinical parameters. VX1 analyzes 3D anatomical and electrical maps of human atria and electrograms to identify dispersed electrograms in real-time.
QIR Suite is deployed locally on dedicated hardware. VX1 is software integrated with existing electrophysiology (EP) lab mapping and recording systems, and is compatible with most EP recording, 3D navigation systems, and mapping catheters.
QIR Suite offers AI-based analysis, detection of heart regions and pathological areas, quantification of over 100 clinical parameters, automatic segmentation, and quantification of blood flow/velocities, pathological volumes, myocardial perfusion, and strain. VX1 provides AI-guided real-time identification of dispersed electrograms (EGMs) during ablation procedures, analyzes 3D maps, and offers cycle length estimation from electrograms.
AI Tool Finder
AI-powered search. Results may not be comprehensive.